ursodeoxycholic acid has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulrab, S; Al-Maweri, S; Halboub, E | 1 |
1 other study(ies) available for ursodeoxycholic acid and Cytokine Release Syndrome
| Article | Year |
|---|---|
Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm.
Topics: Anti-Inflammatory Agents; Apoptosis; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Ursodeoxycholic Acid | 2020 |